One ATP is for the provision of multiple communications satellite subsystems to EADS Astrium. The subsystems are intended for the Telstar 12N telecommunications satellite that will provide coverage over
Two ATP's were received from undisclosed customers to provide advanced satellite subsystems to be integrated into two telecommunications satellites.
MDA is a global communications and information company providing operational solutions to commercial and government organizations worldwide.
MDA's business is focused on markets and customers with strong repeat business potential. In addition, the Company conducts a significant amount of advanced technology development.
MDA's well-established global customer base is served by more than 4,500 employees operating from 11 offices located in
The Company's common shares trade under the symbol TSX:MDA.
Caution Regarding Forward Looking Information and Other Matters
This press release contains certain forward-looking statements and
information which reflect the current view of
With regard to the authorizations to proceed ("ATP's") there can be no
assurance that contracts resulting from the ATP's will be finalized and
entered into by MDA and the third party, or what the total value of the
contracts may be.
You are referred to the risk factors described in MDA's most recent
annual Management's Discussion and Analysis, Annual Information Form
and other documents on file with the Canadian securities regulatory
authorities, available on SEDAR, www.sedar.com or www.mdacorporation.com. All such factors should be considered carefully, as well as other
uncertainties and potential events, and the inherent uncertainty of
forward-looking statements, when making decisions with respect to MDA.
The forward-looking statements and information contained in this press
release represent MDA's views only as of today's date. All such
statements are made pursuant to the "safe harbour" provisions of
applicable Canadian and U.S. securities laws. MDA disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise, other than as required by law, rule or regulation. You
should not place undue reliance on forward-looking statements.